M08.42
Pauciarticular juvenile rheumatoid arthritis, elbow
Clinical Classification Guidelines
Medical Intelligence & Overview
Pauciarticular juvenile rheumatoid arthritis (JRA), also known as juvenile idiopathic arthritis (JIA), is a condition characterized by inflammation in a small number of joints, typically fewer than five. When this form affects the elbow, it can cause pain, swelling, and stiffness, impacting a child's daily activities and development. The ICD-10 code M08.42 specifically identifies cases where the elbow joint is involved. Recognizing the signs and understanding the nature of this condition is essential for managing symptoms and improving quality of life for affected children.
Causes & Symptoms
Clinical Causes: An autoimmune response where the body's immune system mistakenly attacks the joints. Genetic predisposition, with certain genes increasing the risk. Environmental factors that may trigger immune dysregulation, such as infections. Possibility of other underlying autoimmune disorders, although exact causes remain unclear.
Key Symptoms: Swelling and tenderness around the elbow joint. Limited range of motion or stiffness, especially after periods of inactivity. Persistent pain or discomfort in the elbow area. Warmth or redness in the affected joint. Possible asymmetry, with one elbow impacted more than the other. Fatigue or general signs of inflammation in some cases.
Diagnostic & Treatment
Diagnosis Path: Medical history review, focusing on symptom duration and severity. Physical examination of the elbow joint to assess swelling, warmth, and mobility. Blood tests to detect markers of inflammation, such as elevated ESR or CRP. Imaging studies like X-rays or MRI to evaluate joint inflammation and rule out other conditions. Exclusion of other joint disorders or infections that could mimic JRA symptoms.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and swelling. Physical therapy to improve joint flexibility and muscle strength. Regular monitoring to track disease activity and adjust treatment plans. Disease-modifying antirheumatic drugs (DMARDs) when necessary to slow disease progression. Biologic agents may be considered in severe cases to target specific immune system pathways. Pain management strategies and supportive therapies to enhance daily functioning.
Clinical Advice & FAQs
Billing Guidance
Is M08.42 a billable ICD-10 code?
Yes, M08.42 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.42?
Clinical documentation must specify the nature of Pauciarticular juvenile rheumatoid arthritis, elbow and any associated comorbidities for accurate reporting.
Cite this Clinical Reference